| Literature DB >> 25566231 |
Daniel F M Monte1, Adassa G Tavares2, Allan R Albuquerque3, Fábio C Sampaio3, Tereza C R M Oliveira4, Octavio L Franco5, Evandro L Souza2, Marciane Magnani6.
Abstract
Multidrug-resistant Salmonella enterica isolates from human outbreaks or from poultry origin were investigated for their ability to develop direct-tolerance or cross-tolerance to sodium chloride, potassium chloride, lactic acid, acetic acid, and ciprofloxacin after habituation in subinhibitory amounts ( of the minimum inhibitory concentration - (MIC) and of the minimum inhibitory concentration - MIC) of Origanum vulgare L. essential oil (OVEO) at different time intervals. The habituation of S. enterica to OVEO did not induce direct-tolerance or cross-tolerance in the tested strains, as assessed by the modulation of MIC values. However, cells habituated to OVEO maintained or increased susceptibility to the tested antimicrobials agents, with up to fourfold double dilution decrease from previously determined MIC values. This study reports for the first time the non-inductive effect of OVEO on the acquisition of direct-tolerance or cross-tolerance in multidrug-resistant S. enterica strains to antimicrobial agents that are largely used in food preservation, as well as to CIP, the therapeutic drug of salmonellosis.Entities:
Keywords: Salmonella; ciprofloxacin; multidrug-resistant; oregano; tolerance
Year: 2014 PMID: 25566231 PMCID: PMC4271697 DOI: 10.3389/fmicb.2014.00721
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Resistance mechanisms and the minimum inhibitory concentration (MIC) of essential oil from Origanum vulgare L. and ciprofloxacin (CIP) against multidrug-resistant Salmonella enterica strains isolated from human outbreaks or from poultry origin.
| Test strains | Resistance mechanism* | MIC** of OVEO (μL mL-1) | MIC* of CIP (μL mL-1) |
|---|---|---|---|
| Ser 83-Tyr | 2.5 | 0.12 | |
| Active AcrAB-TolC system | 0 | 0 | |
| Ser 83-Tyr | 2.5 | 0.12 | |
| PMRQ- | 5 | 0.5 |
The MIC of the essential oil from O. vulgare L. against multidrug-resistant S. enterica strains isolated from human outbreaks or from poultry origin, with or without habituation to the same stressing agent for 72 h.
| Strains | Treatment | MIC (μL mL-1) | ||
|---|---|---|---|---|
| 24 h* | 48 h* | 72 h* | ||
| Control (0 μL OVEO mL-1) | 2.5 | 2.5 | 2.5 | |
| MIC OVEO (1.25 μL OVEO mL-1) | 2.5 | 1.25 | 0.3 | |
| MIC OVEO (0.6 μL OVEO mL-1) | 2.5 | 1.25 | 0.3 | |
| Control (0 μL OVEO mL-1) | 2.5 | 2.5 | 2.5 | |
| MIC OVEO (1.25 μL OVEO mL-1) | 1.25 | 1.25 | 0.6 | |
| MIC OVEO (0.6 μL OVEO mL-1) | 2.5 | 2.5 | 2.5 | |
| Control (0 μL OVEO mL-1) | 5 | 5 | 5 | |
| MIC OVEO (2.5 μL OVEO mL-1) | 2.5 | 1.25 | 0.3 | |
| MIC OVEO (1.25 μL OVEO mL-1) | 2.5 | 2.5 | 2.5 | |
Minimum inhibitory concentrations of sodium chloride, potassium chloride, acetic acid, and lactic acid against multidrug-resistant S. enterica strains isolated from human outbreaks or from poultry origin, with or without habituation to the essential oil from O. vulgare L. for 72 h.
| Strains | Treatment | Sodium chloride (NaCl) | Potassium chloride (KCL) | Acetic acid | Lactic acid | Ciprofloxacin (CIP) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 h* | 48 h* | 72 h* | 24 h* | 48 h* | 72 h* | 24 h* | 48 h* | 72 h* | 24 h* | 24 h* | 24 h* | 24 h* | 48 h* | 72 h* | ||
| Control (0 μL OVEO mL-1) | 150 | 150 | 150 | 200 | 200 | 200 | 2.5 | 2.5 | 2.5 | 10 | 10 | 10 | 0.12 | 0.12 | 0.12 | |
| MIC OVEO (1.25 μL OVEO mL-1) | 150 | 75 | 75 | 200 | 100 | 75 | 2.5 | 2.5 | 1.25 | 5 | 5 | 1.25 | 0.12 | 0.5 | 0.12 | |
| MIC OVEO (0.6 μL OVEO mL-1) | 150 | 75 | 75 | 200 | 200 | 75 | 2.5 | 2.5 | 1.25 | 5 | 5 | 1.25 | 0.12 | 0.5 | 0.12 | |
| Control (0 μL OVEO mL-1) | 150 | 150 | 100 | 200 | 200 | 200 | 2.5 | 2.5 | 2.5 | 10 | 5 | 5 | 0.12 | 0.12 | 0.12 | |
| MIC OVEO (1.25 μL OVEO mL-1) | 150 | 100 | 75 | 100 | 75 | 50 | 2.5 | 2.5 | 2.5 | 5 | 5 | 5 | 0.12 | 0.12 | 0.12 | |
| MIC OVEO (0.6 μL OVEO mL-1) | 150 | 150 | 150 | 200 | 200 | 100 | 2.5 | 2.5 | 2.5 | 5 | 5 | 5 | 0.12 | 0.12 | 0.12 | |
| Control (0 μL OVEO mL-1) | 150 | 150 | 100 | 200 | 200 | 200 | 2.5 | 2.5 | 2.5 | 10 | 5 | 5 | 0.5 | 0.5 | 0.5 | |
| MIC OVEO (2.5 μL OVEO mL-1) | 50 | 50 | 50 | 200 | 200 | 50 | 2.5 | 2.5 | 1.25 | 5 | 5 | 1.25 | 0.5 | 0.5 | 0.5 | |
| MIC OVEO (1.25 μL OVEO mL-1) | 50 | 50 | 50 | 200 | 200 | 50 | 2.5 | 2.5 | 1.25 | 5 | 5 | 1.25 | 0.5 | 0.5 | 0.5 | |